Ayalon Insurance Comp Ltd. Abb Vie Inc. Transaction History

Ayalon Insurance Comp Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$105.21 - $117.21 $789,075 - $879,075	-7,500 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$102.3 - $112.62 $99,231 - $109,241	-970 Reduced 11.45%	7,500 $814,000
Q2 2020 Jul 07, 2020	BUY	$73.37 - $98.18 $621,443 - $831,584	8,470 New	8,470 $840,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Ayalon Insurance Comp Ltd., based on Form 13F filings with the SEC.

Stay updated on Ayalon Insurance Comp Ltd. with notifications on news.